Peter Garcia
2016 - PDL BioPharma
In 2016, Peter Garcia earned a total compensation of $1.5M as Vice President and Chief Financial Officer at PDL BioPharma, a 3% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $728,578 |
|---|---|
| Salary | $430,301 |
| Stock Awards | $325,384 |
| Other | $58,000 |
| Total | $1,542,263 |
Garcia received $728.6K in non-equity incentive plan, accounting for 47% of the total pay in 2016.
Garcia also received $430.3K in salary, $325.4K in stock awards and $58K in other compensation.
Rankings
In 2016, Peter Garcia's compensation ranked 6,111th out of 14,075 executives tracked by ExecPay. In other words, Garcia earned more than 56.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,111 out of 14,075 | 57th |
Division Manufacturing | 2,232 out of 5,488 | 59th |
Major group Chemicals And Allied Products | 733 out of 1,900 | 61st |
Industry group Drugs | 554 out of 1,543 | 64th |
Industry Biological Products, Except Diagnostic Substances | 105 out of 287 | 63rd |
Source: SEC filing on April 28, 2017.
Garcia's colleagues
We found four more compensation records of executives who worked with Peter Garcia at PDL BioPharma in 2016.
News
ALX ONCOLOGY HOLDINGS CEO Jason Lettmann receives $4.9M in 2023
April 22, 2024
ALX ONCOLOGY HOLDINGS CEO Jaume Pons' 2022 pay falls 63% to $3.7M
April 24, 2023
PDL BioPharma CEO Dominique Monnet's 2019 pay jumps 168% to $6.7M
July 7, 2020
PDL BioPharma CEO John McLaughlin's 2018 pay rises 20% to $4.1M
April 30, 2019